(You can now subscribe to our Economic Times WhatsApp channel) (Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.) Subscribe to The Economic Times Prime and read the ET ePaper online
June 2024
However, certain individuals should consult their doctor before starting treatment, particularly those with: A history of thyroid cancer or endocrine disorders Pancreatitis or gallbladder disease Severe gastrointestinal issues Uncontrolled diabetes or blood sugar fluctuations At Henderson Womens Care, we prioritize patient safety by carefully evaluating medical histories and providing ongoing monitoring throughout treatment
GLP-1, binds to GLP-1R mostly in an -helix conformation with a large surface of contact with both the extra-cellular domain and the seven transmembrane domain 27,30
Heres an overview of the most popular GLP-1 medications and their key features: Semaglutide (Brand names: Ozempic, Wegovy, Rybelsus Features: Once-weekly injection (Ozempic, Wegovy) or daily oral tablet (Rybelsus) Approved for type 2 diabetes (Ozempic, Rybelsus) and weight management (Wegovy) Benefits: Significant weight loss Improved glycemic control Cardiovascular benefits Dulaglutide (Brand name: Trulicity) Features: Once-weekly injection Approved for type 2 diabetes Benefits: Improved glycemic control Moderate weight loss Cardiovascular benefits Tirzepatide (Brand name: Mounjaro ) Features: Once-weekly injection Approved for type 2 diabetes, under review for weight management Dual GIP and GLP-1 receptor agonist Benefits: Significant weight loss Improved glycemic control Potential cardiovascular benefits Key differences: Efficacy: Semaglutide and tirzepatide generally show the most significant weight loss and glycemic control improvements
